Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Acquisitions & Divestments (2021 - 2025)

Kiniksa Pharmaceuticals International (KNSA) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $40.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 53.38% year-over-year to $40.8 million, compared with a TTM value of $199.5 million through Dec 2025, down 16.86%, and an annual FY2025 reading of $199.5 million, down 16.86% over the prior year.
  • Change in Acquisitions & Divestments was $40.8 million for Q4 2025 at Kiniksa Pharmaceuticals International, down from $84.1 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $139.2 million in Q1 2021 and bottomed at $7.5 million in Q1 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $52.5 million, with a median of $45.0 million recorded in 2023.
  • The sharpest move saw Change in Acquisitions & Divestments tumbled 94.61% in 2022, then soared 312.56% in 2024.
  • Year by year, Change in Acquisitions & Divestments stood at $10.0 million in 2021, then soared by 101.0% to $20.1 million in 2022, then surged by 128.75% to $46.0 million in 2023, then skyrocketed by 90.26% to $87.5 million in 2024, then crashed by 53.38% to $40.8 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for KNSA at $40.8 million in Q4 2025, $84.1 million in Q3 2025, and $30.6 million in Q2 2025.